The latest findings from the largest European project in the emerging science of wastewater analysis are presented today by the Europe-wide SCORE group, in association with the EU drugs agency (EMCDDA) (1). The project analysed wastewater in over 50 European cities in 18 European countries in March 2016 to explore the drug-taking behaviours of their inhabitants.
From London to Nicosia and from Oslo to Lisbon, the study analysed daily wastewater samples in the catchment areas of wastewater treatment plants (WWTPs) over a one-week period. Wastewater from approximately 25 million people was analysed for traces of four illicit drugs: amphetamine, cocaine, MDMA (ecstasy) and methamphetamine.
Wastewater based epidemiology is a rapidly developing scientific discipline with the potential for monitoring near-real-time, population-level trends in illicit drug use (2). By sampling a known source of wastewater, such as a sewage influent to a wastewater treatment plant, scientists can now estimate the quantity of drugs used in a community by measuring the levels of illicit drugs and their metabolites excreted in urine (see motion graphic for method) (3).
The SCORE group has been conducting annual wastewater monitoring campaigns since 2011. This is the first time, however, that data are published within only a few months of the campaign, underlining the potential of this method for the timely monitoring of trends in illicit drug use at population level.
The results are released today through an innovative interactive map and chart-based tool allowing the user to look at geographical and temporal patterns and zoom in on results per city (4). The findings offer a valuable snapshot of the drug flow through the cities involved, revealing marked regional variations in drug use patterns:
In this project, SCORE uses a standard protocol and a common quality-control exercise in all locations, making it possible to directly compare illicit drug loads in Europe over a one-week period over six consecutive years.
The EMCDDA adopts a multi-indicator approach to drug monitoring on the principle that no single measure can provide a full picture of the drug situation. It views wastewater analysis as a valuable additional tool in its epidemiological toolkit and one which can provide timely information on a wide spectrum of substances.
Commenting today, EMCDDA Director Alexis Goosdeel said: ‘Wastewater-based epidemiology has demonstrated its potential to become a useful complement to established drug monitoring tools. Its ability to deliver timely data on drug use patterns is particularly relevant against the backdrop of an ever-shifting drugs problem. By detecting changes in drug use patterns, both geographically and over time, it can help health and treatment services respond better to emerging trends and changing treatment needs. We are delighted that the SCORE group has been able to release data for the first time in the same year as the data-collection exercise’.
In 2017, in the margins of the Lisbon Addictions 2017 conference, the EMCDDA will be co‑hosting ‘Testing the waters 2017’, the third international conference on wastewater analysis. Updates at www.emcdda.europa.eu/activities/wastewater-analysis